Insider Trading History of Yu John S

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Yu John S since 2013. This trader's CIK number is 1550545. At the time of last reporting, Yu John S was the CEO and Chairman of Kairos Pharma, Ltd.. (stock ticker symbol KAPA). Also see all insider trading activities at Kairos Pharma, Ltd..

Note that in the past Yu John S also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Kairos Pharma, Ltd. (KAPA) by Yu John S

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 KAPA 4,000 $5,760 0 $0 0 $0

Yearly summary of insider trading at Immunocellular Therapeutics, Ltd. (IMUC) by Yu John S

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2015 IMUC 0 $0 0 $0 25,000 $6,750
2013 IMUC 0 $0 300,000 $871,264 300,000 $74,999


Insider trading activities at 2 companies by Yu John S:

1. Kairos Pharma, Ltd. (KAPA)

2. Immunocellular Therapeutics, Ltd. (IMUC)

Table 1. Insider trading of Kairos Pharma, Ltd. (KAPA) by Yu John S

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-11-20 KAPA Buy 4,000 1.44 5,760

Table 2. Insider trading of Immunocellular Therapeutics, Ltd. (IMUC) by Yu John S

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2015-09-28 IMUC Option Ex 25,000 .27 6,750
2013-10-18 IMUC Sale 32,613 2.85 92,881
2013-11-25 IMUC Option Ex 32,613 .25 8,153
2013-10-21 IMUC Sale 36,006 2.92 105,065
2013-10-21 IMUC Option Ex 36,006 .25 9,001
2013-10-18 IMUC Sale 231,381 2.91 673,318
2013-10-18 IMUC Option Ex 231,381 .25 57,845

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Yu John S (CEO and Chairman of Kairos Pharma, Ltd. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.